ArticleDigestive diseases and sciences2026
Safety and Efficacy of Primary Needle-Knife Fistulotomy in Patients at High Risk for Post-ERCP Pancreatitis: A Prospective Multicenter Pilot Study Comparing Endoscopists with Different Levels of ERCP and NKF Experience.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
BACKGROUND AND
aimsPrimary needle-knife fistulotomy (NKF) may reduce post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) in high-risk patients, but safety data across operators with differing prior ERCP and NKF experience are scarce. We evaluated the efficacy and safety of primary NKF according to prior operator experience.
methodsThis prospective, multicenter, non-randomized pilot study enrolled 139 patients with a naïve ampulla and at least one PEP risk factor at six Korean tertiary centers. Endoscopists were grouped as Group A (limited experience in both ERCP and NKF), Group B (extensive ERCP but limited NKF experience), or Group C (extensive experience in both). Cannulation rate, cannulation time, adverse events, and learning curves were compared.
resultsThe overall biliary cannulation rate was 98.6%, without intergroup difference. Adverse events occurred in 13.6, 4.2, and 0% in Groups A, B, and C, respectively (P = .012). Cannulation time was shortest and total procedure time longest in Group A. Baseline common bile duct diameter and papillary morphology differed significantly across groups, limiting causal attribution of the adverse-event differences to operator experience. The exploratory learning-curve analysis included only eight events, with no significant difference between Groups A and B (P = .09).
conclusionsPrimary NKF achieved high technical success across experience groups. Adverse events were more frequent in Group A; however, non-randomized allocation, baseline anatomical imbalances, heterogeneous post-cannulation management, and sparse event data preclude attributing this difference to operator experience. These hypothesis-generating findings neither establish a competency threshold nor define when primary NKF can be performed independently.
Indexed as
Identifiers
42809068What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.